Status:

COMPLETED

Effectiveness of Enhanced Treatments for Drug Dependence

Lead Sponsor:

University of Pennsylvania

Conditions:

Cocaine Dependence

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

The purpose of this challenge grant is to conduct an initial test of a new, enhanced version of this protocol (telephone monitoring and counseling - enhanced, or TMAC-E), which has been modified to in...

Eligibility Criteria

Inclusion

  • (1) qualify for a DSM-IV diagnosis of cocaine dependence, with some cocaine use in the prior 6 months;
  • (2) be 18 to 75 years of age;
  • (3) have no current psychotic disorder or evidence of dementia severe enough to prevent participation in outpatient treatment;
  • (4) have no acute medical problem requiring immediate inpatient treatment;
  • (5) not be in methadone or other modes of Drug and Alcohol treatment, other than Intensive Outpatient Program;
  • (6) be willing to be randomized and participate in research;
  • (7) because of study follow-up requirements, subjects will be able to provide the name, verified telephone number, and address of at least one contact who can provide locator information on the patient during follow-up. We will include patients with dependence on other substances, provided that they are cocaine dependent and meet other inclusion criteria.

Exclusion

  • have a current psychotic disorder or evidence of dementia severe enough to prevent participation in outpatient treatment;
  • have acute medical problem requiring immediate inpatient treatment;
  • are in methadone or other modes of DA treatment, other than IOP;
  • or cannot provide names of people who can get messages to them for follow up, in the event we cannot locate the participant at their original address and number. Also, if they are court mandated to treatment or otherwise considered a prisoner, they will be ineligible for the study as we have not applied for Subpart C approval.

Key Trial Info

Start Date :

October 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2011

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT01153477

Start Date

October 1 2009

End Date

October 1 2011

Last Update

March 30 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104